2
|
Khazaal O, Cox M, Grodinsky E, Dawod J, Cristancho D, Atsina KB, Ji JY, Neuhaus-Booth E, Ramchand P, Pukenas BA, Kung D, Hurst R, Choudhri O, Burkhardt JK, Kasner SE, Favilla CG. Highly Visible Wall-Timer to Reduce Endovascular Treatment Time for Stroke. STROKE (HOBOKEN, N.J.) 2022; 2:e000300. [PMID: 37588009 PMCID: PMC10431196 DOI: 10.1161/svin.121.000300] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 12/06/2021] [Accepted: 04/26/2022] [Indexed: 08/18/2023]
Abstract
BACKGROUND Endovascular therapy for acute ischemic stroke has revolutionized clinical care for patients with stroke and large vessel occlusion, but treatment remains time sensitive. At our stroke center, up to half of the door-to-groin time is accounted for after the patient arrives in the angio-suite. Here, we apply the concept of a highly visible timer in the angio-suite to quantify the impact on endovascular treatment time. METHODS This was a single-center prospective pseudorandomized study conducted over a 32-week period. Pseudorandomization was achieved by turning the timer on and off in 2-week intervals. The primary outcome was angio-suite-to-groin time, and secondary outcomes were angio-suite-to-intubation time, groin-to-recanalization time, and 90-day modified Rankin scale. A stratified analysis was performed based on type of anesthesia (ie, endotracheal intubation versus not). RESULTS During the 32-week study period, 97 mechanical thrombectomies were performed. The timer was on and off for 38 and 59 cases, respectively. The timer resulted in faster angio-suite-to-groin time (28 versus 33 minutes; P=0.02). The 5-minute reduction in angio-suite-to-groin was maintained after adjusting for intubation status in a multivariate regression (P=0.02). There was no difference in the 90-day modified Rankin scale between groups. The timer impact was consistent across the 32-week study period. CONCLUSIONS A highly visible timer in the angio-suite achieved a meaningful, albeit modest, reduction in endovascular treatment time for patients with stroke. Given the lack of risk and low cost, it is reasonable for stroke centers to consider a highly visible timer in the angio-suite to improve treatment times.
Collapse
Affiliation(s)
- Ossama Khazaal
- Department of Neurology, University of Pennsylvania, Philadelphia, PA (O.K., E.G., J.D., D.C., E.N.-B., P.R., S.E.K., C.G.F.); Department of Radiology, University of Pennsylvania, Philadelphia, PA (M.C., K.-B.A., J.Y.J., B.A.P., R.H.); Department of Neurosurgery, University of Pennsylvania, Philadelphia, PA (D.K., O.C., J.-K.B.)
| | - Mougnyan Cox
- Department of Neurology, University of Pennsylvania, Philadelphia, PA (O.K., E.G., J.D., D.C., E.N.-B., P.R., S.E.K., C.G.F.); Department of Radiology, University of Pennsylvania, Philadelphia, PA (M.C., K.-B.A., J.Y.J., B.A.P., R.H.); Department of Neurosurgery, University of Pennsylvania, Philadelphia, PA (D.K., O.C., J.-K.B.)
| | - Emily Grodinsky
- Department of Neurology, University of Pennsylvania, Philadelphia, PA (O.K., E.G., J.D., D.C., E.N.-B., P.R., S.E.K., C.G.F.); Department of Radiology, University of Pennsylvania, Philadelphia, PA (M.C., K.-B.A., J.Y.J., B.A.P., R.H.); Department of Neurosurgery, University of Pennsylvania, Philadelphia, PA (D.K., O.C., J.-K.B.)
| | - Judy Dawod
- Department of Neurology, University of Pennsylvania, Philadelphia, PA (O.K., E.G., J.D., D.C., E.N.-B., P.R., S.E.K., C.G.F.); Department of Radiology, University of Pennsylvania, Philadelphia, PA (M.C., K.-B.A., J.Y.J., B.A.P., R.H.); Department of Neurosurgery, University of Pennsylvania, Philadelphia, PA (D.K., O.C., J.-K.B.)
| | - Daniel Cristancho
- Department of Neurology, University of Pennsylvania, Philadelphia, PA (O.K., E.G., J.D., D.C., E.N.-B., P.R., S.E.K., C.G.F.); Department of Radiology, University of Pennsylvania, Philadelphia, PA (M.C., K.-B.A., J.Y.J., B.A.P., R.H.); Department of Neurosurgery, University of Pennsylvania, Philadelphia, PA (D.K., O.C., J.-K.B.)
| | - Kofi-Buaku Atsina
- Department of Neurology, University of Pennsylvania, Philadelphia, PA (O.K., E.G., J.D., D.C., E.N.-B., P.R., S.E.K., C.G.F.); Department of Radiology, University of Pennsylvania, Philadelphia, PA (M.C., K.-B.A., J.Y.J., B.A.P., R.H.); Department of Neurosurgery, University of Pennsylvania, Philadelphia, PA (D.K., O.C., J.-K.B.)
| | - Jonathan Y Ji
- Department of Neurology, University of Pennsylvania, Philadelphia, PA (O.K., E.G., J.D., D.C., E.N.-B., P.R., S.E.K., C.G.F.); Department of Radiology, University of Pennsylvania, Philadelphia, PA (M.C., K.-B.A., J.Y.J., B.A.P., R.H.); Department of Neurosurgery, University of Pennsylvania, Philadelphia, PA (D.K., O.C., J.-K.B.)
| | - Elizabeth Neuhaus-Booth
- Department of Neurology, University of Pennsylvania, Philadelphia, PA (O.K., E.G., J.D., D.C., E.N.-B., P.R., S.E.K., C.G.F.); Department of Radiology, University of Pennsylvania, Philadelphia, PA (M.C., K.-B.A., J.Y.J., B.A.P., R.H.); Department of Neurosurgery, University of Pennsylvania, Philadelphia, PA (D.K., O.C., J.-K.B.)
| | - Preethi Ramchand
- Department of Neurology, University of Pennsylvania, Philadelphia, PA (O.K., E.G., J.D., D.C., E.N.-B., P.R., S.E.K., C.G.F.); Department of Radiology, University of Pennsylvania, Philadelphia, PA (M.C., K.-B.A., J.Y.J., B.A.P., R.H.); Department of Neurosurgery, University of Pennsylvania, Philadelphia, PA (D.K., O.C., J.-K.B.)
| | - Bryan A Pukenas
- Department of Neurology, University of Pennsylvania, Philadelphia, PA (O.K., E.G., J.D., D.C., E.N.-B., P.R., S.E.K., C.G.F.); Department of Radiology, University of Pennsylvania, Philadelphia, PA (M.C., K.-B.A., J.Y.J., B.A.P., R.H.); Department of Neurosurgery, University of Pennsylvania, Philadelphia, PA (D.K., O.C., J.-K.B.)
| | - David Kung
- Department of Neurology, University of Pennsylvania, Philadelphia, PA (O.K., E.G., J.D., D.C., E.N.-B., P.R., S.E.K., C.G.F.); Department of Radiology, University of Pennsylvania, Philadelphia, PA (M.C., K.-B.A., J.Y.J., B.A.P., R.H.); Department of Neurosurgery, University of Pennsylvania, Philadelphia, PA (D.K., O.C., J.-K.B.)
| | - Robert Hurst
- Department of Neurology, University of Pennsylvania, Philadelphia, PA (O.K., E.G., J.D., D.C., E.N.-B., P.R., S.E.K., C.G.F.); Department of Radiology, University of Pennsylvania, Philadelphia, PA (M.C., K.-B.A., J.Y.J., B.A.P., R.H.); Department of Neurosurgery, University of Pennsylvania, Philadelphia, PA (D.K., O.C., J.-K.B.)
| | - Omar Choudhri
- Department of Neurology, University of Pennsylvania, Philadelphia, PA (O.K., E.G., J.D., D.C., E.N.-B., P.R., S.E.K., C.G.F.); Department of Radiology, University of Pennsylvania, Philadelphia, PA (M.C., K.-B.A., J.Y.J., B.A.P., R.H.); Department of Neurosurgery, University of Pennsylvania, Philadelphia, PA (D.K., O.C., J.-K.B.)
| | - Jan-Karl Burkhardt
- Department of Neurology, University of Pennsylvania, Philadelphia, PA (O.K., E.G., J.D., D.C., E.N.-B., P.R., S.E.K., C.G.F.); Department of Radiology, University of Pennsylvania, Philadelphia, PA (M.C., K.-B.A., J.Y.J., B.A.P., R.H.); Department of Neurosurgery, University of Pennsylvania, Philadelphia, PA (D.K., O.C., J.-K.B.)
| | - Scott E Kasner
- Department of Neurology, University of Pennsylvania, Philadelphia, PA (O.K., E.G., J.D., D.C., E.N.-B., P.R., S.E.K., C.G.F.); Department of Radiology, University of Pennsylvania, Philadelphia, PA (M.C., K.-B.A., J.Y.J., B.A.P., R.H.); Department of Neurosurgery, University of Pennsylvania, Philadelphia, PA (D.K., O.C., J.-K.B.)
| | - Christopher G Favilla
- Department of Neurology, University of Pennsylvania, Philadelphia, PA (O.K., E.G., J.D., D.C., E.N.-B., P.R., S.E.K., C.G.F.); Department of Radiology, University of Pennsylvania, Philadelphia, PA (M.C., K.-B.A., J.Y.J., B.A.P., R.H.); Department of Neurosurgery, University of Pennsylvania, Philadelphia, PA (D.K., O.C., J.-K.B.)
| |
Collapse
|
8
|
de Havenon A, Alexander MD, Nogueira RG, Haussen DC, Castonguay AC, Linfante I, Johnson MA, Nguyen TN, Mokin M, Zaidat OO. Duration of symptomatic stroke and successful reperfusion with endovascular thrombectomy for anterior circulation large vessel occlusive stroke. J Neurointerv Surg 2021; 13:1128-1131. [PMID: 33526478 DOI: 10.1136/neurintsurg-2020-016961] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/12/2020] [Revised: 12/15/2020] [Accepted: 12/18/2020] [Indexed: 11/04/2022]
Abstract
BACKGROUND It has been reported that longer time intervals from stroke onset to endovascular therapy are associated with lower rates of successful reperfusion in acute ischemic stroke patients with large vessel occlusion. However, procedural variables and potential mechanisms of this association have not been fully elucidated. METHODS We performed a secondary analysis of individual patient data from the North American Solitaire Stent Retriever Acute Stroke (NASA) and Trevo Stent-Retriever Acute Stroke (TRACK) registries. We included patients with occlusion of the internal carotid artery or middle cerebral artery (M1 and M2 segments) who were treated by mechanical thrombectomy within 24 hours of last known normal. The primary outcome was reperfusion, defined as a Thrombolysis In Cerebral Infarction (TICI) score ≥2b. The secondary outcome was reperfusion on the first pass. The primary predictor was duration of symptomatic stroke, defined as time from last known normal to time of final pass. Adjusted logistic regression models were utilized to determine associations between variables and outcome. RESULTS We included 506 patients, of which 401 (79.3%) achieved successful reperfusion (TICI 2b/3). The mean (SD) duration of symptomatic stroke was 6.8 (3.5) hours and in the adjusted logistic regression model the duration of symptomatic stroke was associated with reperfusion (OR 0.90, 95% CI 0.84 to 0.96) and reperfusion on the first pass (OR 0.89, 95% CI 0.83 to 0.95). In that model, the predicted probability of reperfusion was 88% (95% CI 0.83 to 0.92) at 1 hour, 81% (95% CI 0.78 to 0.84) at 6 hours, 70% (95% CI 0.63 to 0.77) at 12 hours, and 42% (95% CI 0.17 to 0.67) at 24 hours (ptrend=0.001). Reperfused patients were significantly younger, more likely to be male, and to have had a balloon guide catheter used during the procedure. CONCLUSION In a real-world cohort of acute ischemic stroke patients with anterior circulation occlusion treated with endovascular therapy, longer duration of symptomatic stroke is associated with lower rates of successful reperfusion and reperfusion on the first pass.
Collapse
Affiliation(s)
- Adam de Havenon
- Department of Neurology, University of Utah, Salt Lake City, Utah, USA.,Department of Radiology, University of Utah, Salt Lake City, Utah, USA
| | | | - Raul G Nogueira
- Neurology, Emory University School of Medicine, Atlanta, Georgia, USA
| | - Diogo C Haussen
- Neurology, Neurosurgery and Radiology, Emory University School of Medicine / Marcus Stroke & Neuroscience Center - Grady Memorial Hospital, Atlanta, Florida, USA
| | | | - Italo Linfante
- Baptist Cardiac and Vascular Institute, Miami, Florida, USA
| | | | - Thanh N Nguyen
- Neurology and Radiology, Boston University School of Medicine, Boston Medical Center, BOSTON, Massachusetts, USA
| | - Maxim Mokin
- Neurosurgery, University of South Florida, Tampa, Florida, USA
| | - Osama O Zaidat
- Neuroscience, Mercy Health Saint Vincent Medical Center, Toledo, Ohio, USA
| |
Collapse
|